Brimonidine Tartrate NDC 0832-1435

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-1435Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-1435Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0832-1435-05	00832143505	1 BOTTLE, DROPPER in 1 CARTON (0832-1435-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Sep 8, 2026
0832-1435-10	00832143510	1 BOTTLE, DROPPER in 1 CARTON (0832-1435-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Sep 8, 2026
0832-1435-15	00832143515	1 BOTTLE, DROPPER in 1 CARTON (0832-1435-15) / 15 mL in 1 BOTTLE, DROPPERMarketed from Sep 8, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine Tartrate
Generic name (nonproprietary): brimonidine tartrate
Active ingredients: Brimonidine tartrate — 1 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217599
Marketing start: Jul 30, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 0832-1435_3f38e30c-bf68-4f67-a949-21313a1d7219SPL ID 3f38e30c-bf68-4f67-a949-21313a1d7219SPL set ID 5a634ed6-f00a-472e-93c9-8dcd496997a2RxCUI 861204UNII 4S9CL2DY2H
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832143505 followed by a unit qualifier and the quantity

Package 00832-1435-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 15, 2025.

Indications (excerpt from the label)

Brimonidine tartrate ophthalmic solution 0.1% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine tartrate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)